ScoreWhy is Haisco Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 7.87% and Operating profit at 23.27% over the last 5 years
2
With a growth in Net Profit of 1089.85%, the company declared Outstanding results in Mar 26
- OPERATING CASH FLOW(Y) Highest at CNY 1,126.55 MM
- ROCE(HY) Highest at 17.13%
- RAW MATERIAL COST(Y) Fallen by -19.75% (YoY)
3
With ROE of 15.84%, it has a very expensive valuation with a 5.14 Price to Book Value
- Over the past year, while the stock has generated a return of 73.68%, its profits have risen by 81.8% ; the PEG ratio of the company is 0.4
- At the current price, the company has a high dividend yield of 1.2
4
Consistent Returns over the last 3 years
- Along with generating 73.68% returns in the last 1 year, the stock has outperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Haisco Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Haisco Pharmaceutical Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Haisco Pharmaceutical Group Co., Ltd.
11.41%
3.04
49.86%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.87%
EBIT Growth (5y)
23.27%
EBIT to Interest (avg)
7.17
Debt to EBITDA (avg)
2.06
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.62
Tax Ratio
4.96%
Dividend Payout Ratio
115.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.07%
ROE (avg)
12.23%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
81
Industry P/E
Price to Book Value
12.83
EV to EBIT
95.91
EV to EBITDA
71.85
EV to Capital Employed
12.20
EV to Sales
12.34
PEG Ratio
0.99
Dividend Yield
0.48%
ROCE (Latest)
12.72%
ROE (Latest)
15.84%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend35What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,212.55 MM
ROCE(HY)
Highest at 22.12%
PRE-TAX PROFIT(Q)
At CNY 289.15 MM has Grown at 197.64%
NET PROFIT(Q)
At CNY 296.62 MM has Grown at 158.39%
RAW MATERIAL COST(Y)
Fallen by -5.55% (YoY
CASH AND EQV(HY)
Highest at CNY 3,919.96 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 7.16 %
DEBTORS TURNOVER RATIO(HY)
Highest at 5.13 times
DIVIDEND PER SHARE(HY)
Highest at CNY 5.13
NET SALES(Q)
At CNY 1,531.61 MM has Grown at 38.13%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Haisco Pharmaceutical Group Co., Ltd.
Net Profit
At CNY 296.62 MM has Grown at 261.34%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 1,212.55 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Pre-Tax Profit
At CNY 289.15 MM has Grown at 197.64%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 296.62 MM has Grown at 158.39%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Sales
At CNY 1,531.61 MM has Grown at 38.13%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Cash and Eqv
Highest at CNY 3,919.96 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 7.16 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 5.13 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Dividend per share
Highest at CNY 5.13
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (CNY)
Raw Material Cost
Fallen by -5.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
